Musculoskeletal

September 28, 2020

Spinal Elements takes its debts to market

September 23, 2020

FDA heaps further misery on Novartis’s Zolgensma

September 11, 2020

A rare yet early-stage win for Galapagos and Gilead in scleroderma

August 25, 2020

Orthopaedics companies’ nightmare quarter

The Covid-19 pandemic has scythed vast sums from joint makers’ Q2 sales. But Medtronic’s summer earnings were better than those for its spring quarter.

August 25, 2020

Ipsen throws itself a bone with palovarotene data dredge

August 21, 2020

Filgotinib was set to struggle, market stats show

August 17, 2020

Unity's efforts do not age well

August 13, 2020

Nippon Shinyaku takes on Sarepta

A new competitor enters the exon 53 skipping niche, and might well take it over.

August 12, 2020

Fulcrum’s biopsy conundrum